Bank of New York Mellon’s Biolase, Inc. BIOL Stock Holding History

Bank of New York Mellon’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4	Closed	-$10K	–	4243
2019 Q3	$10K	Hold	4	–	–	﹤0.01%	4205
2019 Q2	$16K	Hold	4	–	–	﹤0.01%	4194
2019 Q1	$26K	Hold	4	–	–	﹤0.01%	4147
2018 Q4	$11K	Hold	4	–	–	﹤0.01%	4190
2018 Q3	$23K	Hold	4	–	–	﹤0.01%	4203
2018 Q2	$13K	Sell	4 -1	-20%	-$3.77K	﹤0.01%	4192
2018 Q1	$27K	Hold	5	–	–	﹤0.01%	4249
2017 Q4	$27K	Buy	5 +2	+67%	+$14.1K	﹤0.01%	4279
2017 Q3	$20K	Hold	3	–	–	﹤0.01%	4215
2017 Q2	$33K	Hold	3	–	–	﹤0.01%	4183
2017 Q1	$47K	Hold	3	–	–	﹤0.01%	4148
2016 Q4	$52K	Hold	3	–	–	﹤0.01%	4125
2016 Q3	$64K	Hold	3	–	–	﹤0.01%	4106
2016 Q2	$49K	Hold	3	–	–	﹤0.01%	4176
2016 Q1	$53K	Hold	3	–	–	﹤0.01%	4076
2015 Q4	$34K	Hold	3	–	–	﹤0.01%	4234
2015 Q3	$37K	Sell	3 -7	-70%	-$130K	﹤0.01%	4278
2015 Q2	$209K	Buy	10 +1	+11%	+$24.4K	﹤0.01%	3879
2015 Q1	$232K	Buy	9 +6	+200%	+$170K	﹤0.01%	3858
2014 Q4	$96K	Hold	3	–	–	﹤0.01%	4050
2014 Q3	$87K	Hold	3	–	–	﹤0.01%	4075
2014 Q2	$77K	Sell	3 -7	-70%	-$179K	﹤0.01%	4029
2014 Q1	$302K	Hold	10	–	–	﹤0.01%	3742
2013 Q4	$354K	Hold	10	–	–	﹤0.01%	3693
2013 Q3	$228K	Hold	10	–	–	﹤0.01%	3760
2013 Q2	$428K	Buy	+10	New	+$559K	﹤0.01%	3555

Other funds holding BIOL

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of New York Mellon's BIOL Position: Q4 2019 in Review

Bank of New York Mellon sold out of Biolase, Inc. (BIOL) in Q4 2019, closing a stake of 4 shares — an estimated $10K sold.

Bank of New York Mellon first reported a position in BIOL in Q2 2013 and held it in 26 quarters. The position peaked at $428K in Q2 2013. 19 funds tracked by Wall St. Rank hold BIOL as of Q4 2019.

Bank of New York Mellon reported no remaining Biolase, Inc. position as of Q4 2019 after selling out during the quarter.
Bank of New York Mellon sold 4 Biolase, Inc. shares in Q4 2019, an estimated $10K.
Bank of New York Mellon first reported a position in Biolase, Inc. in Q2 2013 and held it in 26 quarters.
Bank of New York Mellon's Biolase, Inc. position peaked at $428K in Q2 2013.
19 funds tracked by Wall St. Rank held Biolase, Inc. as of Q4 2019.

Based on Bank of New York Mellon's 13F filing for Q4 2019, filed 14 Feb 2020.